LILRB2 and hepatocellular carcinoma: Previous studies have already shown that ANGPTL8 physically interacts with PirB in hepatoma cells in mice18, and Zhang Z et al. have recently reported that ANGPTL8 accelerates liver fibrosis by binding with LILRB2 on HSCs41.